COAPT Continued Access: A Continued Clinical Evaluation of the Safety and Effectiveness of the MitraClip NT System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects
COAPT Continued Access Study
Sponsor: Abbott
Enrolling: Male and Female Patients
IRB Number: AAAR5218
U.S. Govt. ID: NCT01626079
Contact: Lauren Privitera: 212-342-3488 /
Additional Study Information: Study for subjects with moderate-to-severe or severe functional mitral regurgitation (MR) and you have been determined to have symptoms due to heart failure despite being treated with currently available therapies, and are not an appropriate candidate for mitral valve surgery.
This study is closed
Susheel Kodali, MD
Do You Qualify?
Have you been treated with available therapies and still have symptoms due to heart failure? Yes No
Do you have COPD that requires home oxygen therapy or chronic oral steroid use? Yes No
Do you have any planned heart surgery in the next 12 months? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Lauren Privitera